Zhang Na, Song Jie, Han Yuchun
School of Pharmacy, Binzhou Medical University, Yantai 264003, China.
CAS Key Laboratory of Colloid, Interface and Chemical Thermodynamics, CAS Research/Education Center for Excellence in Molecular Sciences, Beijing National Laboratory for Molecular Sciences (BNLMS), Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China.
Biomolecules. 2024 Dec 19;14(12):1628. doi: 10.3390/biom14121628.
Due to their high biocompatibility, biodegradability, and facile surface functionalization, phospholipid vesicles as carriers have garnered significant attention in the realm of disease diagnosis and treatment. On the one hand, phospholipid vesicles can function as probes for the detection of various diseases by encapsulating nanoparticles, thereby enabling the precise localization of pathological changes and the monitoring of disease progression. On the other hand, phospholipid vesicles possess the capability to selectively target and deliver therapeutic agents, including drug molecules, genes and immune modulators, to affected sites, thereby enhancing the sustained release of these agents and improving therapeutic efficacy. Recent advancements in nanotechnology have led to an increased focus on the application of phospholipid vesicles in drug delivery, biological detection, gene therapy, and cell mimics. This review aims to provide a concise overview of the structure, characteristics, and preparation techniques of phospholipid vesicles of varying sizes. Furthermore, we will summarize the latest research developments regarding their use as nanomedicines and gene carriers in disease treatment. Additionally, we will elucidate the potential of phospholipid vesicles in facilitating the internalization, controlled release, and targeted delivery of therapeutic substrates. Through this review, we aspire to enhance the understanding of the evolution of phospholipid vesicles within the biological field, outline prospective research, and address the forthcoming challenges associated with phospholipid vesicles in disease diagnosis and treatment.
由于其具有高生物相容性、生物可降解性以及易于进行表面功能化,磷脂囊泡作为载体在疾病诊断和治疗领域已引起了广泛关注。一方面,磷脂囊泡可以通过包裹纳米颗粒作为检测各种疾病的探针,从而实现病理变化的精确定位和疾病进展的监测。另一方面,磷脂囊泡具有将治疗剂(包括药物分子、基因和免疫调节剂)选择性靶向并递送至受影响部位的能力,从而增强这些药剂的持续释放并提高治疗效果。纳米技术的最新进展使得人们越来越关注磷脂囊泡在药物递送、生物检测、基因治疗和细胞模拟物中的应用。本综述旨在简要概述不同大小磷脂囊泡的结构、特性和制备技术。此外,我们将总结其作为纳米药物和基因载体在疾病治疗中的最新研究进展。此外,我们将阐明磷脂囊泡在促进治疗底物的内化、控释和靶向递送方面的潜力。通过本综述,我们希望增进对磷脂囊泡在生物领域发展的理解,概述前瞻性研究,并解决与磷脂囊泡在疾病诊断和治疗中相关的未来挑战。